Cochrane Abstracts
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Perphenazine Versus Low‐potency First‐generation Antipsychotic Drugs for Schizophrenia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433341/1/. Accessed 07 May 2024.
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/1/. Accessed May 7, 2024.
Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/1/
Perphenazine Versus Low‐potency First‐generation Antipsychotic Drugs for Schizophrenia [Internet]. In: Cochrane Abstracts. [cited 2024 May 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/1/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
ID - 433341
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433341/1/
DB - Evidence Central
DP - Unbound Medicine
ER -
